These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 28678648

  • 1. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
    Gao D, Han Y, Yang Y, Herman JG, Linghu E, Zhan Q, Fuks F, Lu ZJ, Guo M.
    Epigenetics; 2017 Jul 03; 12(7):575-583. PubMed ID: 28678648
    [Abstract] [Full Text] [Related]

  • 2. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W, Wu K, Herman JG, Xu X, Yang Y, Dai G, Guo M.
    Clin Epigenetics; 2018 Jul 03; 10():69. PubMed ID: 29796120
    [Abstract] [Full Text] [Related]

  • 3. Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis.
    Zheng R, Gao D, He T, Zhang M, Zhang X, Linghu E, Wei L, Guo M.
    Clin Epigenetics; 2017 Jul 03; 9():50. PubMed ID: 28491151
    [Abstract] [Full Text] [Related]

  • 4. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y, He T, Herman JG, Linghu E, Yang Y, Fuks F, Zhou F, Song L, Guo M.
    Clin Epigenetics; 2017 Jul 03; 9():115. PubMed ID: 29075358
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.
    Wang Y, Zhang Y, Herman JG, Linghu E, Guo M.
    Oncotarget; 2017 Sep 19; 8(41):70035-70048. PubMed ID: 29050260
    [Abstract] [Full Text] [Related]

  • 8. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G, Lin J, Wang W, Sun M, Chen K, Wang F.
    Genet Test Mol Biomarkers; 2017 Feb 19; 21(2):74-79. PubMed ID: 28051879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
    Hu S, Cao B, Zhang M, Linghu E, Zhan Q, Brock MV, Herman JG, Mao G, Guo M.
    Am J Cancer Res; 2015 Feb 19; 5(2):651-62. PubMed ID: 25973304
    [Abstract] [Full Text] [Related]

  • 11. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
    Zhang M, Li X, Herman JG, Gao A, Wang Q, Yao Y, Shen F, He K, Guo M.
    Clin Transl Gastroenterol; 2024 Mar 01; 15(3):e00682. PubMed ID: 38235705
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.
    He T, Zhang M, Zheng R, Zheng S, Linghu E, Herman JG, Guo M.
    Epigenomics; 2017 Jun 01; 9(6):849-862. PubMed ID: 28403629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Altered ARID1A expression in colorectal cancer.
    Erfani M, Hosseini SV, Mokhtari M, Zamani M, Tahmasebi K, Alizadeh Naini M, Taghavi A, Carethers JM, Koi M, Brim H, Mokarram P, Ashktorab H.
    BMC Cancer; 2020 Apr 25; 20(1):350. PubMed ID: 32334542
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.